[HTML] nih.gov

[HTML][HTML] Treatment strategy of EGFR-mutated non-small cell lung cancer

F Tanaka, K Yoneda, M Takenaka… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Song Y, Jia Z, Wang Y, et al. Potential treatment strategy for the rare osimertinib resistant
mutation EGFR L718Q. J Thorac Dis 2020; 12: 2771-80. Zheng Y, Zhou M, Arulananda S, et …
被引用次数：1 相关文章

Treatment strategy of EGFR-mutated non-small cell lung cancer.

F Tanaka, K Yoneda, M Takenaka… - Journal of Thoracic …, 2022 - europepmc.org
Song Y, Jia Z, Wang Y, et al. Potential treatment strategy for the rare osimertinib resistant
mutation EGFR L718Q. J Thorac Dis 2020; 12: 2771-80. Zheng Y, Zhou M, Arulananda S, et …
[HTML] amegroups.org

[HTML][HTML] Treatment strategy of EGFR-mutated non-small cell lung cancer

F Tanaka, K Yoneda, M Takenaka… - Journal of Thoracic …, 2022 - jtd.amegroups.org
Treatment strategy of EGFR -mutated non-small cell lung cancer - Tanaka - Journal of Thoracic
Disease Have a website account?Log In orRegister for exclusive website content. Subscribe …

[引用][C] Treatment strategy of EGFR-mutated non-small cell lung cancer

F Tanaka, K Yoneda, M Takenaka… - Journal of thoracic …, 2022 - pubmed.ncbi.nlm.nih.gov
[PDF] amegroups.cn

[PDF][PDF] Treatment strategy of EGFR-mutated non-small cell lung cancer

F Tanaka, K Yoneda, M Takenaka… - Journal of Thoracic …, 2022 - cdn.amegroups.cn
Song Y, Jia Z, Wang Y, et al. Potential treatment strategy for the rare osimertinib resistant
mutation EGFR L718Q. J Thorac Dis 2020; 12: 2771-80. Zheng Y, Zhou M, Arulananda S, et …

Treatment strategy of EGFR-mutated non-small cell lung cancer

F Tanaka, K Yoneda, M Takenaka… - Journal of Thoracic …, 2022 - jtd.amegroups.org
Treatment strategy of EGFR -mutated non-small cell lung cancer - Tanaka - Journal of Thoracic
Disease Have a website account?Log In orRegister for exclusive website content. Subscribe …